Table of Contents GLP-1 receptor agonists and the origin of thyroid cancer concerns What recent human studies reveal about thyroid safety Interpreting epidemiologic findings in clinical practice Counseling patients about GLP-1 therapy and thyroid risk GLP-1 Receptor Agonists and the Origin of Thyroid Cancer Concerns GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide were first associated with thyroid safety signals during preclinical testing
Last reviewed: July 17, 2026 Last updated: July 17, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
We evaluated the sensitivity of our selected targets to variations in the cut-off thresholds for maximal viral replication rate and maximal biomass production rate
These peptides offer promising insights into cellular health and longevity, advancing anti-aging science
As hormone levels fluctuate during perimenopause, cycles often become irregular
1033 Budapest